Months 6 and beyond: the new equilibrium For most women, sexual function stabilizes after six months on a stable dose
This semaglutide injection, approved by the FDA for chronic weight management, helps adults with obesity or overweight (BMI of 30 or greater, or 27 or greater with at least one weight-related condition) lose weight when combined with a reduced calorie diet and increased physical activity
doi: 10.1172/jci.insight.120360 225 RodigSJGusenleitnerDJacksonDGGjiniEGiobbie-HurderAJinCet al
Wegovy (semaglutide) is a GLP-1 receptor agonist, which means it works by mimicking a natural hormone (GLP-1) that helps regulate your appetite and food intake
Benoit SR, Hora I, Pasquel FJ, Gregg EW, Albright AL, Imperatore G (2020) Trends in emergency department visits and inpatient admissions for hyperglycemic crises in adults with diabetes in the U.S., 2006-2015